日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Metabolic syndrome and immune-related adverse events

代谢综合征和免疫相关不良事件

Lei, Katherine; Patel, Meera J; Liu, Jialiang; Rathod, Rutu Aniruddha; von Itsztein, Mitchell S; Fattah, Farjana J; Mu-Mosley, Hong; SoRelle, Jeffrey A; Park, Jason Y; Xie, Yang; Hughes, Amy E; Kitzman, Heather; Gerber, David E

Innate and adaptive immune features associated with immune-related adverse events

与免疫相关不良事件相关的先天性和适应性免疫特征

Khan, Shaheen; Malladi, Venkat S; von Itzstein, Mitchell S; Mu-Mosley, Hong; Fattah, Farjana J; Liu, Yang; Gwin, Mary E; Park, Jason Y; Cole, Suzanne M; Bhalla, Sheena; Lohrey, Jay; Hsiehchen, David; Moses, Angela; Wang, Tao; Xue, Yaming; Mobley, Angela B; Farrar, J David; Imam, Marjaan; Wu, Michelle; Li, Quan-Zhen; Wakeland, Edward K; Xie, Yang; SoRelle, Jeffrey A; Gerber, David E

Genetic haplotypes in VWA8, OSBPL6, and ADAMTS9-AS2 are associated with immune-related adverse effects in ICI-treated patients with cancer

VWA8、OSBPL6 和 ADAMTS9-AS2 基因单倍型与接受免疫检查点抑制剂治疗的癌症患者的免疫相关不良反应有关。

Raj, Prithvi; Liu, Jialiang; Zhu, Chengsong; Arana, Carlos; J Fattah, Farjana; Mu-Mosley, Hong; Switzer, Benjamin; Park, Jason Y; von Itzstein, Mitchell S; Wakeland, Edward K; Puzanov, Igor; Zakharia, Yousef; Daniels, Gregory A; Shaheen, Montaser F; Xie, Yang; SoRelle, Jeffrey A; Gerber, David E

Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung Cancer.

Exportin 1 抑制剂 Selinexor 联合多西他赛治疗既往接受过治疗的晚期 KRAS 突变型非小细胞肺癌的 I/II 期试验

von Itzstein Mitchell S, Burns Timothy F, Dowell Jonathan E, Horn Leora, Camidge D Ross, York Sally J, Eaton Keith D, Kyle Kelly, Fattah Farjana, Liu Jialiang, Mu-Mosley Hong, Gupta Arjun, Nadeem Urooba, Gao Ang, Zhang Song, Gerber David E

Association of PD-L1 expression with systemic immune parameters in non-small cell lung cancer

PD-L1表达与非小细胞肺癌系统性免疫参数的相关性

Gwin, Mary E; von Itzstein, Mitchell S; Liu, Jialiang; Fattah, Farjana J; Mu-Mosley, Hong; SoRelle, Jeffrey A; Bhalla, Sheena; Dowell, Jonathan E; Rashdan, Sawsan; Park, Jason Y; Yang, Donghan M; Xie, Yang; Gerber, David E

Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer

肺癌患者系统性免疫参数的种族差异

von Itzstein, Mitchell S; Liu, Jialiang; Mu-Mosley, Hong; Fattah, Farjana; Park, Jason Y; SoRelle, Jeffrey A; Farrar, J David; Gwin, Mary E; Hsiehchen, David; Gloria-McCutchen, Yvonne; Wakeland, Edward K; Cole, Suzanne; Bhalla, Sheena; Kainthla, Radhika; Puzanov, Igor; Switzer, Benjamin; Daniels, Gregory A; Zakharia, Yousef; Shaheen, Montaser; Zhang, Jianjun; Xie, Yang; Gerber, David E

Distinct autoantibody profiles across checkpoint inhibitor types and toxicities

不同类型检查点抑制剂及其毒性引起的自身抗体谱差异

Mu-Mosley, Hong; von Itzstein, Mitchell S; Fattah, Farjana; Liu, Jialiang; Zhu, Chengsong; Xie, Yang; Wakeland, Edward K; Park, Jason Y; Kahl, Brad S; Diefenbach, Catherine S; Gerber, David E

FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML

FLT3 抑制剂通过抑制 AML 细胞中的 ERK 来上调 CXCR4 和 E-选择素配体,而 CXCR4/E-选择素抑制可增强 FLT3 靶向治疗对 AML 的抗白血病疗效

Yannan Jia #, Weiguo Zhang #, Mahesh Basyal, Kyung Hee Chang, Lauren Ostermann, Jared K Burks, Charlie Ly, Hong Mu-Mosley, Qi Zhang, Xin Han, William E Fogler, John L Magnani, Arnaud Lesegretain, Anna A Zal, Tomasz Zal, Michael Andreeff

Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX Models

IL15的转基因表达使CD123重定向的T细胞保持较低分化状态,从而在自体AML PDX模型中提高了抗AML活性。

Mu-Mosley, Hong; Ostermann, Lauren; Muftuoglu, Muharrem; Vaidya, Abishek; Bonifant, Challice L; Velasquez, Mireya Paulina; Gottschalk, Stephen; Andreeff, Michael

Humoral and cellular correlates of a novel immune-related adverse event and its treatment

新型免疫相关不良事件的体液和细胞相关性及其治疗

Amrit S Gonugunta #, Mitchell S von Itzstein #, Hong Mu-Mosley, Farjana Fattah, J David Farrar, Angela Mobely, Sawsan Rashdan, Sunny Lai, Salman F Bhai, Bonnie L Bermas, David Karp, Quan-Zhen Li, Edward K Wakeland, David E Gerber